181 results
6-K
EX-99.2
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
, 2023:
Employee stock options expired
Share-based compensation
Comprehensive loss for the period
BALANCE AT MARCH 31, 2023
Ordinary shares
Share
6-K
EX-99.1
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
Accumulated deficit
Total
in USD thousands
BALANCE AT JANUARY 1, 2023
CHANGES FOR THREE MONTHS ENDED MARCH 31, 2023:
Employee stock options expired
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee” or any other similar orders or restrictions or the closure … for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
20-F/A
2023 FY
EX-2.1
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
with any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or contractor of the Company who
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
, access to capital and employee retention. Such ESG matters may also impact our third-party contract manufacturers and other third parties on which we … competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that we or any employee or contractor
6-K
EX-99
jkiy jx8cgh
26 Mar 24
BioLineRx Reports 2023 Financial Results and Recent Corporate
7:06am
S-8
6e2g0
29 Dec 23
Registration of securities for employees
4:20pm
F-3
1anrefjv ql4habv
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
v7zfjyas696
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
yfc8pwzpp
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
w840f
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
hx9pz tqo
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
5m4liuryu13fb807tbo
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
17jef1b1
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
podly1utcg5v5
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
1rvlpx
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
mov36v
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
41ehaq
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am